[size=11]Published Date: 03.12.2022 | 07:10 GMT |[You must be registered and logged in to see this link.][/size]
Georgy Boblyansky, general manager of the Russian pharmaceutical company Vertex, said that this company has entered the Iraqi market and is studying prospects for entering the Iranian market.
He added, in an interview with reporters today: "We started studying the Iranian market, looking at the opportunities that might be available there. In Iraq, we submitted an application to register products for medicines to treat dental diseases. We are not yet thinking of entering the Latin American market."
It is noteworthy that the company decreased this year the volume of exports slightly, compared to the previous year. Georgia may leave the list of countries that import the company's products.
Currently, the company produces medicines to treat many diseases, including gynecological diseases, skin diseases, heart diseases, and ear, nose and throat diseases, as well as medicines to treat flu and cold symptoms.
[You must be registered and logged in to see this link.]